Resources

Alan Bernstein, Julie Gerberding, Edward Holmes, Mike Osterholm, Lynda Stuart, and Holden Thorp consider what COVID-19 can teach us about pandemic preparedness, vaccine development, and public health policy.

What can COVID-19 response teach us about the future of universal influenza vaccine R&D? Read our latest white paper for findings from our 2020 literature review, interviews and survey with insights from over 200 professionals from 45 countries.

Astonishing progress toward successful COVID-19 vaccines has built momentum to conquer infectious disease threats. In our latest video, infectious disease experts Harvey Fineberg, Julie Gerberding, Edward Holmes, Michael Osterholm and Lynda Stuart say a full-court press for a universal influenza vaccine should be next.  

Pandemic expert Harvey Fineberg hopes COVID-19 is the wake-up call the world needs to prevent the next pandemic. How can we learn from COVID-19 in a future some have described as an “age of pandemics,” during which outbreaks will become increasingly frequent? We zero in on the pathogen we know best: influenza.

[Survey is Now Closed] Take our survey and help identify key factors driving the unprecedented effort to produce SARS-CoV-2 vaccines that can inform the development of new vaccines to prevent future pandemics, and particularly of a universal influenza vaccine.

Pardis Sabeti shares her insights around the phenomenal scientific and technical response to COVID-19, demonstrating the power of collaborative research and pointing the way to protecting the world from future pandemics. Blog by Stacey Knobler, Senior Director of Influenza Vaccine Innovation at the Sabin Vaccine Institute.

Part III: Celebrating influenza thought leaders & advocates

June 9, 2020

June 10, 2020

Part Two: Celebrating the contributions of influenza researchers